| 301230 Stock | | | 27.35 0.35 1.30% |
Founder
Hongjian Zhang is CoFounder Officer of PharmaResources Co Ltd
| Address | Building 12, Shanghai, China, 201201 |
| Web | https://www.pharmaresources.cn |
PharmaResources Co Ltd (301230) is traded on Shenzhen Stock Exchange in China and employs 1,047 people. PharmaResources is listed under Biotechnology category by Fama And French industry classification.
Management Performance
PharmaResources Leadership Team
Elected by the shareholders, the PharmaResources' board of directors comprises two types of representatives: PharmaResources inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaResources. The board's role is to monitor PharmaResources' management team and ensure that shareholders' interests are well served. PharmaResources' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaResources' outside directors are responsible for providing unbiased perspectives on the board's policies.
PharmaResources Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaResources a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in PharmaResources Stock
PharmaResources financial ratios help investors to determine whether PharmaResources Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmaResources with respect to the benefits of owning PharmaResources security.